Masimo

Medical technology company that develops, manufactures, and markets noninvasive patient monitoring products.

Launch date

1989

Employees

1001-5000 people

Market cap

Enterprise valuation

$6.8b (Public information from Sep 2024)

Neuchâtel Neuchâtel (HQ)

http://masimo.com

https://twitter.com/masimoinnovates http://www.facebook.com/pages/Masimo/104085566293466 https://www.linkedin.com/company/masimo-corporation

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	1.1b	1.2b	2.0b	2.0b	2.1b	2.2b	2.4b
% growth	22 %	8 %	64 %	1 %	2 %	6 %	6 %
EBITDA	284m	311m	346m	266m	398m	438m	464m
% EBITDA margin	25 %	25 %	17 %	13 %	19 %	20 %	20 %
Profit	240m	230m	144m	81.5m	99.8m	167m	202m
% profit margin	21 %	19 %	7 %	4 %	5 %	8 %	9 %
EV / revenue	12.3x	12.6x	3.8x	3.0x	2.0x	2.0x	1.9x
EV / EBITDA	49.6x	50.3x	22.5x	23.3x	10.8x	10.4x	9.4x
R&D budget	119m	137m	191m	175m	-	-	-
R&D % of revenue	10 %	11 %	9 %	9 %	-	-	-

Date	Investors	Amount	Round
Jul 2000	Signatures Capital	N/A	-
Aug 2007	N/A	N/A	IPO
Nov 2016	Bill & Melinda Gates Foundation	$5.0m	Grant
Aug 2017	Robeco	N/A	Post IPO Equity
Aug 2022*	N/A	$750m	Post IPO Equity
Total Funding		$5.0m

ACQUISITION by Masimo Mar 2020

Spire Corporation

ACQUISITION by Masimo Mar 2012

ACQUISITION by Masimo Feb 2022

ACQUISITION by Masimo Apr 2023

ACQUISITION by Masimo Nov 2020